AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-79
Results: 26-50/79

Authors: LICATO LL KEKU TO WURZELMANN JI MURRAY SC WOOSLEY JT SANDLER RS BRENNER DA
Citation: Ll. Licato et al., IN-VIVO ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASES IN RAT INTESTINAL NEOPLASIA, Gastroenterology, 113(5), 1997, pp. 1589-1598

Authors: HELM JF RUSSO MW SIMPSON KN RANSOHOFF DF SANDLER RS
Citation: Jf. Helm et al., SCREENING FOR COLORECTAL-CANCER (CRC) BY FECAL OCCULT BLOOD TESTING (FOBT) IS COST-EFFECTIVE, BUT IS IT AFFORDABLE, Gastroenterology, 112(4), 1997, pp. 18-18

Authors: EISEN GM MAYCON ZR SANDLER RS MURRAY SC
Citation: Gm. Eisen et al., IS OBESITY A RISK FACTOR FOR BARRETTS-ESOPHAGUS, Gastroenterology, 112(4), 1997, pp. 557-557

Authors: HELM JF QUADE D RUSSO MW SIMPSON KN RANSOHOFF DF SANDLER RS
Citation: Jf. Helm et al., WHAT DO WE GAIN BY SCREENING FOR COLORECTAL-CANCER (CRC) WITH 6 TESTSFOR FECAL OCCULT BLOOD, AND AT WHAT COST, Gastroenterology, 112(4), 1997, pp. 576-576

Authors: KEKU TO GALANKO JA MURRAY SC SANDLER RS
Citation: To. Keku et al., RECTAL MUCOSAL PROLIFERATION, DIETARY FACTORS AND RISK OF COLORECTAL ADENOMAS, Gastroenterology, 112(4), 1997, pp. 590-590

Authors: RUSSO MW HELM JF BIDDLE AK SANDLER RS
Citation: Mw. Russo et al., SERIAL FECAL OCCULT BLOOD TESTING DETECTS MORE CANCERS AT A LOWER COST, Gastroenterology, 112(4), 1997, pp. 648-648

Authors: SANDLER RS GALANKO JA MURRAY SC HELM JF WOOSLEY JT
Citation: Rs. Sandler et al., ASPIRIN AND NONSTEROIDAL ANTIINFLAMMATORY AGENTS PREVENT COLORECTAL ADENOMAS, Gastroenterology, 112(4), 1997, pp. 650-650

Authors: EISEN GM SANDLER RS MURRAY S GOTTFRIED M
Citation: Gm. Eisen et al., THE RELATIONSHIP BETWEEN GASTROESOPHAGEAL REFLUX DISEASE AND ITS COMPLICATIONS WITH BARRETTS-ESOPHAGUS, The American journal of gastroenterology, 92(1), 1997, pp. 27-31

Authors: WURZELMANN JI SILVER A SCHREINEMACHERS DM SANDLER RS EVERSON RB
Citation: Ji. Wurzelmann et al., IRON INTAKE AND THE RISK OF COLORECTAL-CANCER, Cancer epidemiology, biomarkers & prevention, 5(7), 1996, pp. 503-507

Authors: GODLEY PA CAMPBELL MK MILLER C GALLAGHER P MARTINSON FE MOHLER JL SANDLER RS
Citation: Pa. Godley et al., CORRELATION BETWEEN BIOMARKERS OF OMEGA-3-FATTY-ACID CONSUMPTION AND QUESTIONNAIRE DATA IN AFRICAN-AMERICAN AND CAUSCASIAN UNITED-STATES MALES WITH AND WITHOUT PROSTATIC-CARCINOMA, Cancer epidemiology, biomarkers & prevention, 5(2), 1996, pp. 115-119

Authors: GODLEY PA CAMPBELL MK GALLAGHER P MARTINSON FEA MOHLER JL SANDLER RS
Citation: Pa. Godley et al., BIOMARKERS OF ESSENTIAL FATTY-ACID CONSUMPTION AND RISK OF PROSTATIC-CARCINOMA, Cancer epidemiology, biomarkers & prevention, 5(11), 1996, pp. 889-895

Authors: SANDLER RS
Citation: Rs. Sandler, EPIDEMIOLOGY AND RISK-FACTORS FOR COLORECTAL-CANCER, Gastroenterology clinics of North America, 25(4), 1996, pp. 717

Authors: EISEN GM STRAUS WL SANDLER RS MURRAY SC WURZELMANN J SESSIONS JT
Citation: Gm. Eisen et al., HEALTH-STATUS IN CROHNS-DISEASE - COMPARISON OF THE RATING FORM OF IBD PATIENT CONCERNS IN AFRICAN AND NON-AFRICAN AMERICANS, Gastroenterology, 110(4), 1996, pp. 15-15

Authors: RUSSO MW HELM JF SIMPSON KN RANSOHOFF DF WURZELMANN JI SANDLER RS
Citation: Mw. Russo et al., WEIGHING THE BENEFITS AND RISKS OF LOW-DOSE ASPIRIN IN PRIMARY PREVENTION OF COLORECTAL-CANCER (CRC), Gastroenterology, 110(4), 1996, pp. 36-36

Authors: STRAUS WL EISEN GM SANDLER RS MURRAY SC WURZELMANN J SESSIONS J
Citation: Wl. Straus et al., CROHNS-DISEASE, HEALTH-CARE UTILIZATION, AND POSSIBLE BARRIERS TO CARE IN AFRICAN AND NON-AFRICAN AMERICANS, Gastroenterology, 110(4), 1996, pp. 42-42

Authors: WURZELMANN JI GODLEY P GALLAGHER P MURRAY SC SANDLER RS
Citation: Ji. Wurzelmann et al., ERYTHROCYTE OMEGA-3-FATTY-ACIDS DO NOT PREDICT COLORECTAL ADENOMAS INHUMANS, Gastroenterology, 110(4), 1996, pp. 47-47

Authors: WURZELMANN JI SILVER A SCHREINEMACHERS DM SANDLER RS EVERSON RB
Citation: Ji. Wurzelmann et al., IRON AND THE RISK OF COLORECTAL-CANCER, Gastroenterology, 110(4), 1996, pp. 47-47

Authors: EISEN GM SANDLER RS MURRAY SC GOTTFRIED M
Citation: Gm. Eisen et al., THE ASSOCIATION BETWEEN GASTROESOPHAGEAL REFLUX DISEASE AND ITS COMPLICATIONS WITH BARRETTS-ESOPHAGUS, Gastroenterology, 110(4), 1996, pp. 101-101

Authors: SANDLER RS MURRAY SC GOTTFRIED M
Citation: Rs. Sandler et al., ENVIRONMENTAL RISK-FACTORS FOR BARRETTS-ESOPHAGUS, Gastroenterology, 110(4), 1996, pp. 101-101

Authors: LICATO LL KEKU TO SANDLER RS BRENNER DA
Citation: Ll. Licato et al., JNK AND ERK KINASES ARE ACTIVATED IN DMH-INDUCED COLONIC TUMORS, Gastroenterology, 110(4), 1996, pp. 551-551

Authors: RUSSO MW MURRAY SC WURZELMANN JI WOOSLEY JT SANDLER RS
Citation: Mw. Russo et al., PLASMA SELENIUM LEVELS AND THE RISK OF COLORECTAL ADENOMAS, Gastroenterology, 110(4), 1996, pp. 585-585

Authors: STRAUS WL EISEN GM SANDLER RS MURRAY SC WURZELMANN J SESSIONS J
Citation: Wl. Straus et al., RACE AND CROHNS-DISEASE - CLINICAL AND THERAPEUTIC COMPARISON OF AFRICAN-AMERICANS AND NON-AFRICAN AMERICANS, REPORT OF A MULTICENTER SURVEY, Gastroenterology, 110(4), 1996, pp. 1021-1021

Authors: TSENG M MURRAY SC KUPPER LL SANDLER RS
Citation: M. Tseng et al., MICRONUTRIENTS AND THE RISK OF COLORECTAL ADENOMAS, American journal of epidemiology, 144(11), 1996, pp. 1005-1014

Authors: MURRAY SC SANDLER RS KEKU TO LYLES CM MILLIKAN RC BANGDIWALA SI KUPPER LL JIANG WH ULSHEN MH
Citation: Sc. Murray et al., COMPARISON OF RECTAL MUCOSAL PROLIFERATION MEASURED BY PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IMMUNOHISTOCHEMISTRY AND WHOLE CRYPT DISSECTION, Cancer epidemiology, biomarkers & prevention, 4(7), 1995, pp. 715-720

Authors: SAHAI A NISSIM I SANDLER RS TANNEN RL
Citation: A. Sahai et al., PROSTAGLANDIN F-2-ALPHA-INDUCED AND 12-O-TETRADECANOYLPHORBOL-13-ACETATE-INDUCED ALTERATIONS IN THE PATHWAYS OF RENAL AMMONIAGENESIS, Journal of the American Society of Nephrology, 5(10), 1995, pp. 1792-1798
Risultati: 1-25 | 26-50 | 51-75 | 76-79